Bio­haven re­cruits a Kar­dashi­an to help sell mi­graine drug; GSK li­cens­es lentivi­ral tech to Or­chard

→ Bio­haven has en­list­ed the help of Khloé Kar­dashi­an to help pro­mote their new­ly ap­proved mi­graine drug Nurtec. She’ll be lead­ing a vir­tu­al cam­paign to en­dorse the drug by em­pow­er­ing “peo­ple with mi­graine to share their sto­ries in an on­line com­mu­ni­ty.”

→ Gene ther­a­py play­er Or­chard Ther­a­peu­tics has turned to Glax­o­SmithK­line to li­cense their pro­pri­etary lentivi­ral sta­ble cell line tech­nol­o­gy for Or­chard’s in­ves­ti­ga­tion­al hematopoi­et­ic stem cell gene ther­a­pies for Wiskott Aldrich syn­drome and trans­fu­sion-de­pen­dent be­ta tha­lassemia.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER